Main and combined effects of musculoskeletal pain frequency and avoidant coping on sickness absence: findings from a prospective cohort study.
DOI:
https://doi.org/10.2340/16501977-1212Abstract
OBJECTIVE: Musculoskeletal pain and avoidant coping predicts sickness absence, but how these 2 predictors relate to each other is unknown. We examined the main and combined effects of musculoskeletal pain and avoidant, behavioural coping on incidence of sickness absence. DESIGN AND SUBJECTS: Prospective cohort study of a sample of middle-aged Danes, economically active in 2006, reporting functional limitations due to musculoskeletal pain, n = 3115. METHODS: Data included surveys from 2000 and 2006 and register data from 2007. Outcome was sickness absence exceeding 2 consecutive weeks in 2007. The main effect of self-reported pain frequency and avoidant coping on sickness absence was analysed by multivariate logistic regression. The combined effect was calculated as departure from multiplicativity and by the inclusion of a product term. RESULTS: Daily pain and use of avoidant coping were both associated with sickness absence in multiple adjusted analyses, odds ratio (OR)daily pain = 1.83 (95% confidence interval (CI) 1.51-2.21) and OR(avoidant coping) = 1.52 (95% CI 1.24-1.88) (main effects). A modest combined effect of musculoskeletal pain and avoidant coping on sickness absence was suggested (p = 0.286). CONCLUSION: Avoidant coping and daily pain are both associated with sickness absence, but showed no strong signs of interactive effects. Clinicians should be aware of both factors.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.